(Q32064218)

6 July 2017

1 reference

title

Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia (English)

1 reference

6 July 2017

main subject

prostatic hypertrophy

1 reference

Holtgrewe HL

1

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

6 July 2017

1 reference

6 July 2017

volume

51

1 reference

6 July 2017

issue

4A Suppl

1 reference

6 July 2017

page(s)

1-7

1 reference

Transurethral prostatectomy: practice aspects of the dominant operation in American urology

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Transurethral incision of prostate compared with transurethral resection of prostate in 132 matching cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Transurethral incision of prostate (TUIP): 646 cases in 15 years--a chronological appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Transurethral incision versus transurethral resection of the prostate. A subjective and objective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Transurethral Incision of the Prostate: An Objective and Subjective Evaluation of Long-Term Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Objective and subjective comparison of transurethral resection, transurethral incision and balloon dilatation of the prostate. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Transurethral resection versus incision of the prostate: a randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Prostatectomy: patients' perception and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

A Placebo-controlled Double-blind Study of the Effect of Phenoxybenzamine in Benign Prostatic Obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Alpha 1 adrenergic receptors in canine lower genitourinary tissues: insight into development and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

The role of transabdominal ultrasound in the preoperative evaluation of patients with benign prostatic hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

Impact of prostate size on the outcome of transurethral laser evaporation of the prostate for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900048-X

7 January 2021

10.1016/S0090-4295(98)00048-X

Identifiers

DOI

1 reference

6 July 2017

1 reference